Skip to content

The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block

A Dose Response Study for Duration of Analgesia Using Bupivacaine and Ropivacaine for Infragluteal Parabiceps Sciatic Block

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01272921
Enrollment
142
Registered
2011-01-10
Start date
2010-11-30
Completion date
Unknown
Last updated
2017-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Duration of Motor Block May Vary Between 12-36 Hrs

Brief summary

The duration of motor block for infragluteal parabiceps sciatic nerve block following total knee replacement may vary between 12-36 hrs depending on the amount of local anesthetic given.

Interventions

DRUGBupivacaine

Varying doses to determine the duration of analgesia

DRUGRopivacaine

Varying doses to determine the duration of analgesia

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (\>18 years of age) who are undergoing elective total knee arthroplasty will be included in the study.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Duration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIEL3 daysSubject reported and investigator measured motor and sensory blockade of the sciatic nerve with less than 10ml of 0.5% bupivacaine and ropivacaine after ultrasound-guided nerve-stimulator-assisted needle positioning beneath the common investing external layer (CIEL).

Secondary

MeasureTime frameDescription
Cumulative Probabilities for Needle Positioning Above and Below CIEL.1 DayThe cumulative probability distributions for the minimal current to evoke a motor response with the needle tip positioned external (above) to the common investing extraneural layer (CIEL) and the cumulative probability distribution for the needle tip postioned internal (below) to the CIEL were sought. The difference in the mean minimum threshold current (mA) for the external (above) and internal (below) CIEL positioning were calculated.

Countries

United States

Participant flow

Recruitment details

Subjects undergoing primary tricompartmental total knee replacement at Northwestern Memorial Hospital were asked to participate. 174 patients were approached. 142 subjects were recruited to participate.

Pre-assignment details

Exclusion criteria: subject refusal to be included in the study, contraindications to regional anesthesia, inability to elicit an evoked motor response less than or equal to 1 mA, history of allergy to amide local anesthetics, presence of a progressive neurological deficit, opioid tolerant subjects, presence of coagulopathy, infection, or pregnancy

Participants by arm

ArmCount
GROUP 1
Varying does to determine duration of analgesia following a sciatic nerve block Bupivacaine : Varying doses to determine the duration of analgesia
69
GROUP 2
Varying does to determine duration of analgesia following a sciatic nerve block Ropivacaine : Varying doses to determine the duration of analgesia
70
Total139

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation21

Baseline characteristics

CharacteristicGROUP 2GROUP 1Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
36 Participants37 Participants73 Participants
Age, Categorical
Between 18 and 65 years
34 Participants32 Participants66 Participants
Age, Continuous64.70 years
STANDARD_DEVIATION 9.26
66.93 years
STANDARD_DEVIATION 9.21
65.81 years
STANDARD_DEVIATION 9.27
Region of Enrollment
United States
70 participants69 participants139 participants
Sex: Female, Male
Female
43 Participants44 Participants87 Participants
Sex: Female, Male
Male
27 Participants25 Participants52 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 690 / 70
serious
Total, serious adverse events
0 / 690 / 70

Outcome results

Primary

Duration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIEL

Subject reported and investigator measured motor and sensory blockade of the sciatic nerve with less than 10ml of 0.5% bupivacaine and ropivacaine after ultrasound-guided nerve-stimulator-assisted needle positioning beneath the common investing external layer (CIEL).

Time frame: 3 days

ArmMeasureGroupValue (MEDIAN)
Above CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELMotor: < 10ml10 Hours
Above CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELMotor: >/= 10ml21 Hours
Above CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELSensory: <10ml9 Hours
Above CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELSensory: >/= 10ml20 Hours
Below CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELSensory: >/= 10ml14 Hours
Below CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELMotor: < 10ml7 Hours
Below CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELSensory: <10ml8 Hours
Below CIELDuration of Motor and Sensory Block of the Sciatic With 0.5% Bupivacaine and Ropivacaine After Ultrasound-guided Nerve-stimulator-Assisted Needle Positioning Beneath the CIELMotor: >/= 10ml15 Hours
Comparison: The sample selected for this study,70 per drug group (or 10 in each of the 7 groups), achieves 88% power to detect a minimal difference of 4 hours in duration at a significance level (α) of 0.05 and a standard deviation of 3 hours using Williams test. We chose a difference of 4 hours as this was the interval used for assessment in the postoperative period at night. We sought to detect a difference that was equal to 1 observation period difference.p-value: 0.0595% CI: [-17, -6]Wilcoxon (Mann-Whitney)
Comparison: The sample selected for this study,70 per drug group (or 10 in each of the 7 groups), achieves 88% power to detect a minimal difference of 4 hours in duration at a significance level (α) of 0.05 and a standard deviation of 3 hours using Williams test. We chose a difference of 4 hours as this was the interval used for assessment in the postoperative period at night. We sought to detect a difference that was equal to 1 observation period difference.p-value: 0.0595% CI: [-15, -6]Wilcoxon (Mann-Whitney)
Comparison: The sample selected for this study,70 per drug group (or 10 in each of the 7 groups), achieves 88% power to detect a minimal difference of 4 hours in duration at a significance level (α) of 0.05 and a standard deviation of 3 hours using Williams test. We chose a difference of 4 hours as this was the interval used for assessment in the postoperative period at night. We sought to detect a difference that was equal to 1 observation period difference.p-value: 0.0595% CI: [-10, -4]Wilcoxon (Mann-Whitney)
Comparison: The sample selected for this study,70 per drug group (or 10 in each of the 7 groups), achieves 88% power to detect a minimal difference of 4 hours in duration at a significance level (α) of 0.05 and a standard deviation of 3 hours using Williams test. We chose a difference of 4 hours as this was the interval used for assessment in the postoperative period at night. We sought to detect a difference that was equal to 1 observation period difference.p-value: 0.0595% CI: [-7, -2]Wilcoxon (Mann-Whitney)
Secondary

Cumulative Probabilities for Needle Positioning Above and Below CIEL.

The cumulative probability distributions for the minimal current to evoke a motor response with the needle tip positioned external (above) to the common investing extraneural layer (CIEL) and the cumulative probability distribution for the needle tip postioned internal (below) to the CIEL were sought. The difference in the mean minimum threshold current (mA) for the external (above) and internal (below) CIEL positioning were calculated.

Time frame: 1 Day

ArmMeasureValue (MEAN)
Above CIELCumulative Probabilities for Needle Positioning Above and Below CIEL.0.52 Amplitude (mA)
Below CIELCumulative Probabilities for Needle Positioning Above and Below CIEL.0.19 Amplitude (mA)
p-value: <0.00195% CI: [0.49, 0.54]Z score
p-value: <0.00195% CI: [0.18, 0.21]Z score

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026